Invasive breast carcinoma - IARC

2942. Tornos C, Silva EG, Ordonez NG,
Gershenson DM, Young RH, Scully RE
(1995). Endometrioid carcinoma of the
ovary with a prominent spindle-cell component,
a source of diagnostic confusion.
A report of 14 cases. Am J Surg Pathol 19:
1343-1353.
2943. Tot T (2000). The cytokeratin profile of
medullary carcinoma of the breast.
Histopathology 37: 175-181.
2944. Towfighi J, Simmonds MA, Davidson
EA (1983). Mucin and fat emboli in mucinous
carcinomas. Cause of hemorrhagic
cerebral infarcts. Arch Pathol Lab Med
107: 646-649.
2945. Traiman P, Bacchi CE, De Luca LA,
Uemura G, Nahas NJ, Nahas EA, Pontes A
(1999). Vulvar carcinoma in young patients
and its relationship with genital warts. Eur
J Gynaecol Oncol 20: 191-194.
2946. Treffers PE, Hanselaar AG,
Helmerhorst TJ, Koster ME, van Leeuwen
FE (2001). [Consequences of diethylstilbestrol
during pregnancy; 50 years later still a
significant problem]. Ned Tijdschr
Geneeskd 145: 675-680.
2947. Treilleux T, Mignotte H, Clement-
Chassagne C, Guastalla P, Bailly C (1999).
Tamoxifen and malignant epithelial-nonepithelial
tumours of the endometrium: report
of six cases and review of the literature.
Eur J Surg Oncol 25: 477-482.
2 9 4 8 . Tremblay G, Pearse AGE (2001).
Histochemistry of oxidative enzyme systems
in human thyroid with special reference
to Askanazy cells. J Pathol Bacteriol
80: 353-358.
2949. Trimble EL (1996). Melanomas of the
vulva and vagina. Oncology (Huntingt) 10:
1017-1023.
2950. Trimble EL, Lewis JL Jr., Williams LL,
Curtin JP, Chapman D, Woodruff JM, Rubin
SC, Hoskins WJ (1992). Management of
vulvar melanoma. Gynecol Oncol 45: 254-
258.
2951. Trivedi P, Dave K, Shah M, Karelia N,
Patel D, Wadhwa M (1998). Hepatoid carcinoma
of the ovary--a case report. Eur J
Gynaecol Oncol 19: 167-169.
2952. Trojani M, De Mascarel I, Coquet M,
Coindre JM, De Mascarel A (1989).
[Osteoclastic type giant cell carcinoma of
the breast]. Ann Pathol 9: 189-194.
2953. Trojani M, Guiu M, Trouette H, De
Mascarel I, Cocquet M (1992). Malignant
adenomyoepithelioma of the breast. An
immunohistochemical, cytophotometric,
and ultrastructural study of a case with
lung metastases. Am J Clin Pathol 98: 598-
602.
2954. Troncone G, Martinez JC, Palombini
L, De Rosa G, Mugica C, Rodriguez JA,
Zeppa P, Di Vizio D, Lucariello A, Piris MA
(1998). Immunohistochemical expression
of mdm2 and p21WAF1 in invasive cervical
cancer: correlation with p53 protein and
high risk HPV infection. J Clin Pathol 51:
754-760.
2955. Tsang WY, Chan JK (1996). Endocrine
ductal carcinoma in situ (E-DCIS) of the
breast: a form of low-grade DCIS with distinctive
clinicopathologic and biologic
characteristics. Am J Surg Pathol 20: 921-
943.
2956. Tsang WYW, Chan JKC (1996).
Endocrine ductal carcinoma in situ (E-
DCIS) of the breast: a form of low-grade
DCIS with distinctive clinicopathologic and
biologic characteristics. Am J Surg Pathol
20: 921-943.
2957. Tseng CJ, Pao CC, Tseng LH, Chang
CT, Lai CH, Soong YK, Hsueh S, Jyu-Jen H
(1997). Lymphoepithelioma-like carcinoma
of the uterine cervix: association with
Epstein-Barr virus and human papillomavirus.
Cancer 80: 91-97.
2958. Tsongalis GJ, Ried A Jr. (2001). HER2:
the neu prognostic marker for breast cancer.
Crit Rev Clin Lab Sci 38: 167-182.
2959. Tsou HC, Teng DH, Ping XL,
Brancolini V, Davis T, Hu R, Xie XX,
Gruener AC, Schrager CA, Christiano AM,
Eng C, Steck P, Ott J, Tavtigian SV,
Peacocke M (1997). The role of MMAC1
mutations in early-onset breast cancer:
causative in association with Cowden syndrome
and excluded in BRCA1-negative
cases. Am J Hum Genet 61: 1036-1043.
2960 . Tsuda H, Callen DF, Fukutomi T,
Nakamura Y, Hirohashi S (1994). Allele loss
on chromosome 16q24.2-qter occurs frequently
in breast cancers respectively of
differences in phenotype and extent of
spread. Cancer Res 54: 513-517.
2961. Tsuda H, Takarabe T, Susumu N,
Inazawa J, Okada S, Hirohashi S (1997).
Detection of numerical and structural
alterations and fusion of chromosomes 16
and 1 in low-grade papillary breast carcinoma
by fluorescence in situ hybridization.
Am J Pathol 151: 1027-1034.
2962. Tsuda HH (2001). Prognostic and predictive
value of c-erbB-2 (HER-2/neu) gene
amplification in human breast cancer.
Breast Cancer 8: 38-44.
2963. Tsuji T, Kawauchi S, Utsunomiya T,
Nagata Y, Tsuneyoshi M (1997).
Fibrosarcoma versus cellular fibroma of
the ovary: a comparative study of their proliferative
activity and chromosome aberrations
using MIB-1 immunostaining, DNA
flow cytometry, and fluorescence in situ
hybridization. Am J Surg Pathol 21: 52-59.
2964. Tsukamoto N, Nakamura M,
Ishikawa H (1976). Case report: sclerosing
stromal tumor of the ovary. Gynecol Oncol
4: 335-339.
2965. Tsuura Y, Hiraki H, Watanabe K,
Igarashi S, Shimamura K, Fukuda T, Suzuki
T, Seito T (1994). Preferential localization of
c-kit product in tissue mast cells, basal
cells of skin, epithelial cells of breast, small
cell lung carcinoma and seminoma/dysgerminoma
in human: immunohistochemical
study on formalin-fixed, paraffinembedded
tissues. Virchows Arch 424 :
135-141.
2966. Tuncer ZS, Vegh GL, Fulop V, Genest
DR, Mok SC, Berkowitz RS (2000).
Expression of epidermal growth factor
receptor-related family products in gestational
trophoblastic diseases and normal
placenta and its relationship with development
of postmolar tumor. Gynecol Oncol
77: 389-393.
2967. Twiggs LB, Okagaki T, Phillips GL,
Stroemer JR, Adcock LL (1981).
Trophoblastic pseudotumor-evidence of
malignant disease potential. G y n e c o l
Oncol 12: 238-248.
2968. Tyagi SP, Saxena K, Rizvi R, Langley
FA (1979). Foetal remnants in the uterus
and their relation to other uterine heterotopia.
Histopathology 3: 339-345.
2969. Uchiyama M, Iwasaka T, Matsuo N,
Hachisuga T, Mori M, Sugimori H (1997).
Correlation between human papillomavirus
positivity and p53 gene overexpression
in adenocarcinoma of the uterine
cervix. Gynecol Oncol 65: 23-29.
2970. Ueda G, Fujita M, Ogawa H, Sawada
M, Inoue M, Tanizawa O (1993).
Adenocarcinoma in a benign cystic teratoma
of the ovary: report of a case with a
long survival period. Gynecol Oncol 48:
259-263.
2971. Ueda H, Togashi K, Konishi I, Kataoka
ML, Koyama T, Fujiwara T, Kobayashi H,
Fujii S, Konishi J (1999). Unusual appearances
of uterine leiomyomas: MR imaging
findings and their histopathologic backgrounds.
Radiographics 19 Spec No: S131-
S145.
2972. Uehara T, Izumo T, Kishi K, Takayama
S, Kasuga T (1991). Stromal melanocytic
foci ("blue nevus") in step sections of the
uterine cervix. Acta Pathol Jpn 41: 751-756.
2973. Uehara T, Takayama S, Takemura T,
Kasuga T (1991). Foci of stromal
melanocytes (so-called blue naevus) of the
uterine cervix in Japanese women.
Virchows Arch A Pathol Anat Histopathol
418: 327-331.
2974. Uehira K, Hashimoto H, Tsuneyoshi
M, Enjoji M (1993). Transitional cell carcinoma
pattern in primary carcinoma of the
fallopian tube. Cancer 72: 2447-2456.
2975. Ueki M, Sano T, Okamura S, Iito Y,
Kitsuki K, Sugimoto O (1982). [Clinical diagnosis
of well differentiated cervical adenocarcinoma
with plentiful mucous secretion].
Nippon Sanka Fujinka Gakkai Zasshi
34: 1846-1852.
2976. UICC (2002). TNM classification of
malignant tumors. Sixth ed. John Wiley &
Sons: New York.
2977. Ulbright TM, Alexander RW, Kraus FT
(1981). Intramural papilloma of the vagina:
evidence of Mullerian histogenesis.
Cancer 48: 2260-2266.
2978. Ulbright TM, Roth LM (1985).
Metastatic and independent cancers of
the endometrium and ovary: a clinicopathologic
study of 34 cases. Hum Pathol
16: 28-34.
2979. Ulbright TM, Roth LM, Brodhecker
CA (1986). Yolk sac differentiation in germ
cell tumors. A morphologic study of 50
cases with emphasis on hepatic, enteric,
and parietal yolk sac features. Am J Surg
Pathol 10: 151-164.
2980. Ulbright TM, Roth LM, Stehman FB
(1984). Secondary ovarian neoplasia. A
clinicopathologic study of 35 cases.
Cancer 53: 1164-1174.
2981. Underwood PB Jr., Smith RT (1971).
Carcinoma of the vagina. JAMA 217: 46-52.
2982. Unkila-Kallio L, Tiitinen A, Wahlstrom
T, Lehtovirta P, Leminen A (2000).
Reproductive features in women developing
ovarian granulosa cell tumour at a fertile
age. Hum Reprod 15: 589-593.
2983. Uziel T, Savitsky K, Platzer M, Ziv Y,
Helbitz T, Nehls M, Boehm T, Rosenthal A,
Shiloh Y, Rotman G (1996). Genomic
Organization of the ATM gene. Genomics
33: 317-320.
2984. Vahteristo P, Bartkova J, Eerola H,
Syrjakoski K, Ojala S, Kilpivaara O,
Tamminen A, Kononen J, Aittomaki K,
Heikkila P, Holli K, Blomqvist C, Bartek J,
Kallioniemi OP, Nevanlinna H (2002). A
CHEK2 genetic variant contributing to a
substantial fraction of familial breast cancer.
Am J Hum Genet 71: 432-438.
2985. Vaizey C, Burke M, Lange M (1999).
Carcinoma of the male breast - a review of
91 patients from the Johannesburg
Hospital breast clinics. S Afr J Surg 37: 6-8.
2986. van't Veer LJ, Dai H, Van de Vijver
MJ, He YD, Hart AA, Mao HL, van der Kooy
K, Marton MJ, Witteveen AT, Schreiber
GJ, Kerkhoven RM, Roberts C, Linsley PS,
Bernards R, Friend SH (2002). Gene expression
profiling predicts clinical outcome of
breast cancer. Nature 415: 530-536.
2987. van Belzen MJ, Hiel JA, Weemaes
CM, Gabreels FJ, van Engelen BG, Smeets
DF, van den Heuvel LP (1998). A double
missense mutation in the ATM gene of a
Dutch family with ataxia telangiectasia.
Hum Genet 102: 187-191.
2988. Van Bogaert LJ, Maldague P (1977).
Histologic variants of lipid-secreting carcinoma
of the breast. Virchows Arch A
Pathol Anat 375: 345-353.
2989. Van de Vijver MJ (1999). The pathology
of familial breast cancer: The pre-
BRCA1/BRCA2 era: historical perspectives.
Breast Cancer Res 1: 27-30.
2990. Van de Vijver MJ, He YD, van't Veer
LJ, Dai H, Hart AA, Voskuil DW, Schreiber
GJ, Peterse JL, Roberts C, Marton MJ,
Parrish M, Atsma D, Witteveen A, Glas A,
Delahaye L, van der Velde T, Bartelink H,
Rodenhuis S, Rutgers ET, Friend SH,
Bernards R (2002). A gene-expression signature
as a predictor of survival in breast
cancer. N Engl J Med 347: 1999-2009.
2991. van der Putte SC (1994). Mammarylike
glands of the vulva and their disorders.
Int J Gynecol Pathol 13: 150-160.
2992. van der Putte SC, van Gorp LH (1994).
Adenocarcinoma of the mammary-like
glands of the vulva: a concept unifying
sweat gland carcinoma of the vulva, carcinoma
of supernumerary mammary glands
and extramammary Paget's disease. J
Cutan Pathol 21: 157-163.
2993. van Diest PJ, Baak JPA (1991). The
morphometric prognostic index is the
strongest prognosticator in premenopausal
lymph node-negative and
lymph node-positive breast cancer
patients. Hum Pathol 22: 326-330.
2994. Van Dorpe J, De Pauw A, Moerman P
(1998). Adenoid cystic carcinoma arising in
an adenomyoepithelioma of the breast.
Virchows Arch 432: 119-122.
2995. Van Hoeven KH, Drudis T, Cranor ML,
Erlandson RA, Rosen PP (1993). Low-grade
adenosquamous carcinoma of the breast.
A clinocopathologic study of 32 cases with
ultrastructural analysis. Am J Surg Pathol
17: 248-258.
2996. van Ingen G, Schoemaker J, Baak JP
(1991). A testosterone-producing tumour in
the mesovarium. Pathol Res Pract 187: 362-
370.
2997. Vanderstichele S, Elhage A, Verbert-
Scherrer A, Robert Y, Querleu D, Crepin G
(1996). [Granulosa cell tumors: a case
located in the broad ligament of the uterus
with normal ovaries]. J Gynecol Obstet
Biol Reprod (Paris) 25: 47-52.
2998. Vang R, Kempson RL (2002).
Perivascular epithelioid cell tumor
('PEComa') of the uterus: a subset of HMB-
45-positive epithelioid mesenchymal neoplasms
with an uncertain relationship to
pure smooth muscle tumors. Am J Surg
Pathol 26: 1-13.
2999. Vang R, Medeiros LJ, Fuller GN,
Sarris AH, Deavers M (2001). Non-
Hodgkin's lymphoma involving the gynecologic
tract: a review of 88 cases. Adv Anat
Pathol 8: 200-217.
3000. Vang R, Medeiros LJ, Ha CS, Deavers
M (2000). Non-Hodgkin's lymphomas
involving the uterus: a clinicopathologic
analysis of 26 cases. Mod Pathol 13: 19-28.
References 419